Vident Advisory’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.8M Buy
63,187
+61,011
+2,804% +$11.2M 0.09% 216
2026
Q1
$411K Sell
2,176
-9
-0.4% -$1.9K ﹤0.01% 1353
2025
Q4
$434K Buy
2,185
+129
+6% +$26.1K ﹤0.01% 1237
2025
Q3
$417K Sell
2,056
-10
-0.5% -$1.77K ﹤0.01% 1266
2025
Q2
$364K Buy
+2,066
New +$311K ﹤0.01% 1214

Other funds holding THC

Vident Advisory's THC Position: Q2 2026 in Review

Vident Advisory increased its Tenet Healthcare (THC) stake by 2,804% in Q2 2026, buying an estimated $11.2M and bringing the position to 63,187 shares worth $11.8M. The position accounts for 0.09% of the portfolio, ranked #216.

Vident Advisory first reported a position in THC in Q2 2025 and has held it in 5 quarters since. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Vident Advisory held 63,187 shares of Tenet Healthcare worth $11.8M as of Q2 2026.
  • Vident Advisory bought 61,011 Tenet Healthcare shares in Q2 2026, an estimated $11.2M.
  • Tenet Healthcare made up 0.09% of Vident Advisory's portfolio in Q2 2026, its #216 holding.
  • Vident Advisory first reported a position in Tenet Healthcare in Q2 2025 and has held it in 5 quarters since.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.